Cargando…
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents
The present article describes the design, synthesis, in vitro urease inhibition, and in silico molecular docking studies of a novel series of nitrothiazolacetamide conjugated to different thioquinazolinones. Fourteen nitrothiazolacetamide bearing thioquinazolinones derivatives (8a-n) were synthesize...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821706/ https://www.ncbi.nlm.nih.gov/pubmed/35132095 http://dx.doi.org/10.1038/s41598-022-05736-4 |
_version_ | 1784646458414202880 |
---|---|
author | Sohrabi, Marzieh Nazari Montazer, Mohammad Farid, Sara Moghadam Tanideh, Nader Dianatpour, Mehdi Moazzam, Ali Zomorodian, Kamiar Yazdanpanah, Somayeh Asadi, Mehdi Hosseini, Samanesadat Biglar, Mahmood Larijani, Bagher Amanlou, Massoud Barazandeh Tehrani, Maliheh Iraji, Aida Mahdavi, Mohammad |
author_facet | Sohrabi, Marzieh Nazari Montazer, Mohammad Farid, Sara Moghadam Tanideh, Nader Dianatpour, Mehdi Moazzam, Ali Zomorodian, Kamiar Yazdanpanah, Somayeh Asadi, Mehdi Hosseini, Samanesadat Biglar, Mahmood Larijani, Bagher Amanlou, Massoud Barazandeh Tehrani, Maliheh Iraji, Aida Mahdavi, Mohammad |
author_sort | Sohrabi, Marzieh |
collection | PubMed |
description | The present article describes the design, synthesis, in vitro urease inhibition, and in silico molecular docking studies of a novel series of nitrothiazolacetamide conjugated to different thioquinazolinones. Fourteen nitrothiazolacetamide bearing thioquinazolinones derivatives (8a-n) were synthesized through the reaction of isatoic anhydride with different amine, followed by reaction with carbon disulfide and KOH in ethanol. The intermediates were then converted into final products by treating them with 2-chloro-N-(5-nitrothiazol-2-yl)acetamide in DMF. All derivatives were then characterized through different spectroscopic techniques ((1)H, (13)C-NMR, MS, and FTIR). In vitro screening of these molecules against urease demonstrated the potent urease inhibitory potential of derivatives with IC(50) values ranging between 2.22 ± 0.09 and 8.43 ± 0.61 μM when compared with the standard thiourea (IC(50) = 22.50 ± 0.44 μM). Compound 8h as the most potent derivative exhibited an uncompetitive inhibition pattern against urease in the kinetic study. The high anti-ureolytic activity of 8h was confirmed against two urease-positive microorganisms. According to molecular docking study, 8h exhibited several hydrophobic interactions with Lys10, Leu11, Met44, Ala47, Ala85, Phe87, and Pro88 residues plus two hydrogen bound interactions with Thr86. According to the in silico assessment, the ADME-Toxicity and drug-likeness profile of synthesized compounds were in the acceptable range. |
format | Online Article Text |
id | pubmed-8821706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88217062022-02-09 Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents Sohrabi, Marzieh Nazari Montazer, Mohammad Farid, Sara Moghadam Tanideh, Nader Dianatpour, Mehdi Moazzam, Ali Zomorodian, Kamiar Yazdanpanah, Somayeh Asadi, Mehdi Hosseini, Samanesadat Biglar, Mahmood Larijani, Bagher Amanlou, Massoud Barazandeh Tehrani, Maliheh Iraji, Aida Mahdavi, Mohammad Sci Rep Article The present article describes the design, synthesis, in vitro urease inhibition, and in silico molecular docking studies of a novel series of nitrothiazolacetamide conjugated to different thioquinazolinones. Fourteen nitrothiazolacetamide bearing thioquinazolinones derivatives (8a-n) were synthesized through the reaction of isatoic anhydride with different amine, followed by reaction with carbon disulfide and KOH in ethanol. The intermediates were then converted into final products by treating them with 2-chloro-N-(5-nitrothiazol-2-yl)acetamide in DMF. All derivatives were then characterized through different spectroscopic techniques ((1)H, (13)C-NMR, MS, and FTIR). In vitro screening of these molecules against urease demonstrated the potent urease inhibitory potential of derivatives with IC(50) values ranging between 2.22 ± 0.09 and 8.43 ± 0.61 μM when compared with the standard thiourea (IC(50) = 22.50 ± 0.44 μM). Compound 8h as the most potent derivative exhibited an uncompetitive inhibition pattern against urease in the kinetic study. The high anti-ureolytic activity of 8h was confirmed against two urease-positive microorganisms. According to molecular docking study, 8h exhibited several hydrophobic interactions with Lys10, Leu11, Met44, Ala47, Ala85, Phe87, and Pro88 residues plus two hydrogen bound interactions with Thr86. According to the in silico assessment, the ADME-Toxicity and drug-likeness profile of synthesized compounds were in the acceptable range. Nature Publishing Group UK 2022-02-07 /pmc/articles/PMC8821706/ /pubmed/35132095 http://dx.doi.org/10.1038/s41598-022-05736-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sohrabi, Marzieh Nazari Montazer, Mohammad Farid, Sara Moghadam Tanideh, Nader Dianatpour, Mehdi Moazzam, Ali Zomorodian, Kamiar Yazdanpanah, Somayeh Asadi, Mehdi Hosseini, Samanesadat Biglar, Mahmood Larijani, Bagher Amanlou, Massoud Barazandeh Tehrani, Maliheh Iraji, Aida Mahdavi, Mohammad Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
title | Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
title_full | Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
title_fullStr | Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
title_full_unstemmed | Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
title_short | Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
title_sort | design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821706/ https://www.ncbi.nlm.nih.gov/pubmed/35132095 http://dx.doi.org/10.1038/s41598-022-05736-4 |
work_keys_str_mv | AT sohrabimarzieh designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT nazarimontazermohammad designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT faridsaramoghadam designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT tanidehnader designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT dianatpourmehdi designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT moazzamali designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT zomorodiankamiar designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT yazdanpanahsomayeh designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT asadimehdi designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT hosseinisamanesadat designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT biglarmahmood designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT larijanibagher designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT amanloumassoud designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT barazandehtehranimaliheh designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT irajiaida designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents AT mahdavimohammad designandsynthesisofnovelnitrothiazolacetamideconjugatedtodifferentthioquinazolinonederivativesasantiureaseagents |